C-EHRN Podcast Series #4: Mental Health, a humbug or an alarming topic?

The COVID-19 pandemic has profoundly affected mental health. Prior to the pandemic, marginalised communities already experienced a disproportionate risk of mental health conditions, along with consistently poorer mental health outcomes. It is commonly acknowledged that mental health should become an essential part of any pandemic response, particularly for marginalised communities in general and people who use drugs. However, that is yet not the case.

We talked to Jakub Gren of the Institute of Psychiatry and Neurology in Warsaw, Ben Collins and Nia Dunbar of ReShape/International HIV Partnerships, and Eliza Kurcevic of Eurasian Harm Reduction Association (EHRA). Following the session, NPS and Mental Health: humbug or an alarming situation? at the 5th European Harm Reduction Conference 2021 in Prague, our guests discussed the vulnerable communities’ main barriers in accessing mental health care and support. In addition, they told us what works and what does not.

What do you think?

Listen to the podcast and share your thoughts with us!

#HRAtWork #CEHRN #HarmReduction

Equality & Human Rights | The Core of Harm Reduction

Today is Human Rights Day. Every year on 10 December, Human Rights is observed worldwide, “to proclaim the inalienable rights that everyone is entitled to as a human being.” As announced by the UN, the 2021 theme of the Day is EQUALITY – Reducing inequalities, advancing human rights.

COVID-19 has started to be referred to as the inequality virus in recent times. Since the beginning of the pandemic, pre-existing inequalities have been exposed and exacerbated. As a response, international awareness days this year have emphasised the political, social, cultural and economic importance of upholding equity and human rights with renewed strength. An example of this has been the focus of the recently endorsed international World AIDS Day. In alignment with the 2030 Agendawhich is rich in slowly-but-surely approaching elimination goals, including AIDS, HIV, and deep-rooted forms of discrimination.

Today’s Human Rights Day is a crucial and opportune moment for human rights and drug policy reform movements for at least two reasons. On the one hand, it affirms that the war on drugs continues to sustain abusive policing, over-incarceration, coercion and punishment globally. On the other, it highlights the profoundly unequal outcomes of such repressive drug policies.

To mark Human Rights Day, the IDPC has shared its open letter to Ms Ghada Waly, Executive Director, United Nations Office on Drugs and Crime, with a call to reform drug policies that entrench inequality. The letter “issues a strong statement on International Human Rights Day, calling on states to change the drug laws, policies and practices that violate health and human rights, and entrench inequality.” Please read the letter and ask your organisation to sign.

However, before you decide to sign such a letter, perhaps you would like to inform yourself more in-depth about current discussions on decriminalisation policies? During the 5th European Harm Reduction Conference 2021, EHRC21, we had a lively session titled “Drug policy: decriminalisation – the next logical step for Europe?” in which we discussed what you might be asking yourself now. What are the arguments for decriminalisation? If criminalisation can improve public health and human rights drastically, what are some of the complex and challenging questions that remain? You can watch it here

Also, remember to check the session titled “Mainstreaming Human Rights & Evidence-based Law Enforcement”. This EHRC21 session could also be a valuable look-back since in here essential discussions took place regarding the role that law enforcement agencies ought to have in addressing the needs of people who use drugs. Please watch it here

Today also marks the end of the #16DayActivism Challenge, which started on the International Day of Elimination of Violence against Women. The joint action by the International Network of People who Use Drugs (INPUD) and the Women and Harm Reduction International Network (WHRIN), addressing violence, stigma, and discrimination against women who use drugs, shares its concluding remarks today, on Human Rights Day. Please read them here. 

Finally, today we are also launching the C-EHRN Podcast Series. To kick off our long-awaited podcast series’ idea, we held roundtable sessions during the EHRC21, talking to harm reductionists on several topics. We happily and excitedly present you with the first episode of the series about Human Rights.

For this session, we had four guests; Irena Molnar of ReGeneration, Machteld Busz of MainLINE, Sabrina Sanchez of ESWA and Aura Roig of Metzineres; four strong women representing the core of their work with boldness, kindness, sincerity and fire.
“We are the ones that avoid talking about human rights. Instead, we legitimise our services from a social control point of view. We need to break this cycle and indicate that we do our work for the health and well-being of the people.” said Aura Roig. 

Would you agree? Do we tend to forget that everything we do is in the name of equal human rights?
Listen to the podcast here and share your opinion with us.

The alarming decline in testing on the 40th year of the fight against AIDS

Every year on 1st December, the world commemorates World AIDS Day. A day we unite to remember those who have died from AIDS-related illnesses and reflect upon our worldwide responses to the HIV/AIDS epidemic.

Today marks the 40th year of the fight against AIDS. A benchmark. The theme of World AIDS Day 2021 is “End inequalities. End AIDS”, aiming to highlight the growing inequalities in access to essential HIV services. As we experience a new pandemic, this becomes more relevant than ever. COVID-19 has exacerbated inequalities, and impacted people living with HIV/AIDS, particular in terms of access to testing, treatment and health services.

There are alarming statistics mentioned in the newly-shared press release “HIV, viral hepatitis, and STIs: Let’s make up for lost time against the epidemics!” by the Coalition Plus and EuroTEST initiative, launched on 28th November 2021, the last day of European Testing Week.

A study conducted in 44 countries proves a 35% drop in HIV screenings between 2019 and 2020 among key populations. The number is even higher among sex workers, who were severely affected by the COVID-19 pandemic, with 59%.

Inequality defines infection patterns
The newly launched Global Aids Strategy 2021 – 2026, aims to respond to the inequalities that exist between key populations in different countries and regions. Although key populations have been able to maintain access to life-saving HIV services in some settings, such as pre-exposure prophylaxis (PrEP) and harm reduction – even during COVID-19 lockdowns -, there is a critical and sharp decline in testing caused by the very pandemic that is affecting those most marginalized and underserved.

Building upon this framework, and Political Declaration from last June, on this day we call on the following priority actions to ensure that testing, treatment and care remains accessible for the already marginalized and underserved communities we work for and with.

Intensify and redouble efforts to scale up comprehensive harm reduction for people who use drugs in all settings, including needle-syringe programmes, opioid substitution therapy, as well as prevention, diagnosis and treatment of HIV/AIDS, viral hepatitis, tuberculosis community-led outreach and psychosocial support.

Ensure that sexual and reproductive health and rights services are non-judgmental and non-discriminating, developing programmes to eliminate HIV-related stigma and discrimination, while fostering initiatives that address the cross-cutting dimensions of stigma and discriminations faces by key populations.

Urgently expand access to combination HIV prevention, including PrEP and harm reduction. To ensure that services articulate person-centred and integrated care models that focus on quality of live outcomes beyond viral suppression goals.

Gender-responsive harm reduction programmes for people (including adolescents and young people) who use stimulant drugs or other new psychoactive substances must be introduced and scaled up.

Take urgent actions against the criminalizing laws, policies, and law enforcement practices against  people who use drugs, sex workers, migrants, people of diverse SOGIESC, racialiced people, as well as for the redress of criminalization’s negative effects on HIV, viral hepatitis and other health issues.

Strengthen community-led and community-based harm reduction programmes and to advance community leadership and advocacy, ensuring adequate resources, funding, and enabling eviroments. Within interventions among key populations, a significant increase in resources is needed for combination harm reduction services for people who inject drugs.

Ending AIDS by 2030
Do you also agree that ending inequalities would end AIDS? What does your organisation or you personally do to reach the elimination goals by 2030? What are your recommendations to end AIDS by 2030? Share them online with the hashtag #HRAtWork. We are here to support and strengthen your work.

UNODC Webinar
The UNODC is organising a webinar called “Reflecting on the persistent inequalities that prevent progress in ending the AIDS pandemic” on 2nd December, 10:00-11:30 CET.
Please click here and join the meeting directly tomorrow.

#HepatitisCantWait … neither should we

Today is World Hepatitis Day, #WHD21. Every year on 28th July, civil society organisations, among many others, call on people from across the world to take action and raise awareness of hepatitis. This year’s campaign is another valid point, also acclaimed by WHO: #HepatitisCantWait.

With a person dying every 30 seconds from a hepatitis-related illness, people affected by hepatitis cannot wait to end stigma and discrimination especially now that the current #COVID19 crisis negatively affected hepatitis testing and treatment, leaving many more people unaware and unassisted.
How can health inclusion be exempt from agendas, one wonders?

According to our Monitoring Report 2020, persistent stigmatisation and restrictive policies towards drug use are some of the roughest feeders of deprived, vulnerable communities.
How can countries wait for further harmful facts whilst an inclusive continuum of health care guarantees stronger and more equal societies? 

National guidelines for HCV testing and treatment must include people who use drugs (PWUD) as well as people who inject drugs (PWID) and must allow for low threshold and community-based care to positively impact a #HepFreeFuture states the Monitoring Report 2020 Executive Summary.
How can governments wait to trigger more inclusive health regulations?

Our 2019 briefing paper “HCV in People Who Use Drugs: results from civil society monitoring in Europe” concluded that the main barriers to address HCV among PWID include a lack of funding, knowledge, awareness, dedicated health workers, political support in general, as well as weakness of CSOs and legal barriers.
How can the hands of European Health NGOs’ be tied with existential struggles; shouting #BringBackOperatingGrants whilst #EU4HealthNGOs is the obvious path to take?

The ongoing pandemic has proven all healthcare gaps to remain resolutely in place. If we are to #EliminateHepatitis by 2030, we urgently need to focus on community-led and community-based preventions, #HealthInclusion, testing and treatment.

Let us work collectively for a future where hepatitis was a joke of the past.
Visit worldhepatitisday.org and see how you can get involved for such a future.
Because #HepatitisCantWait, neither should we.

COVID-19 Resource Centre

To support people who use drugs and other marginalized and underserved communities, as well as health and social workers delivering services under challenging conditions to bring this outbreak to a close, Correlation – European Harm Reduction Network is developing this Coronavirus Resource Centre. This capacity-building initiative complements our advocacy activities and the Joint Position on the Continuity of Harm Reduction Services During the COVID-19 Crisis that we published together with the Eurasian Harm Reduction Network, and the Rights Reporter Foundation

This Resource Centre brings together contributions, materials, experiences of our members, partners and allies. New/Updated materials come first, as situations change very quickly.

If you discover any out-of-date links or if there would be any links that could be included, please, let us know at this address: rpgayo@correlation-net.org

 

STATEMENTS | POSITION PAPERS | ADVOCACY

Coalition Plus, IDPC, HRI, INPUD, C-EHRN, INHSU, TAG | COVID-19: An Opportunity For POlicy Reform [June, 26th]

RCC-THV | Call to Action in Response to COVID-19 [May, 14th]

UNAIDS | Sex Workers Must not be Left Behind in the Response to COVID-19 [April, 8th]

TGEU | COVID-19 & Trans People [April, 6th]

INPUD, HRI, EHRA, IDPC et al | Call to Action COVID-19 – Special Rapporteur on the Right to Health [March, 31st]

Nobody Left Outside | EU and national government COVID-19 responses must reach everyone – including marginalised people [March, 26th]

UN Human Rights Experts | No Exceptions with COVID-19: Everyone Has the Right to Live-Saving Interventions | [March, 26th]

EATG | EATG statement on the evolving COVID-19 pandemic [March, 25th]

PICUM | The COVID-19 pandemic: We Need Urgent Measures to Protect People and Mend the Cracks in our Health, Social Protection and Migration Systems [March, 25th]

EUPHA | Statement by the EUPHA Migrant and ethnic minority health section on COVID-19 – CALL FOR ACTION [March, 24th]

UNAIDS | Rights in the time of COVID-19. Lessons from HIV for an effective, community-led response | Infographic | [March, 20th]

C-EHRN & EHRA | Harm Reduction Must Go On [March, 19th]

Human Rights Watch | Human Rights Dimensions of COVID-19 Response [March, 19th]

Global Rights / Susanna Ronconni | Prisoners Rights Matter! Statement | Article [March, 19th]

FEANTSA | COVID-19: “Staying Home” Not an Option for People Experiencing Homelessness [March, 18th]

ICRSE | COVID-19: Sex Workers Need Immediate Financial Support and Protection [March, 18th]

Penal Reform International | Coronavirus: Healthcare and Human Rights of People in Prison [March, 16th]

DPNSEE | Public Appeal to Protect Vulnerable Groups from COVID-19 [March, 2nd]

 

GUIDELINES | PROTOCOLS | GOOD PRACTICE

 

DRUG USE

EHRA | Harm reduction service delivery to people who use drugs during a public health emergency: Examples from the COVID-19 pandemic in selected countries [November 2020]

Manitoba Harm Reduction Network | Outreach Guidelines During COVID-19 [Updated, March, 26th]

EuroNPUD & INPUD & Respect Drug Users Rights | COVID-19: Advice for People who Use Drugs [March, 26th]

Forum Substitution Praxis | Newsletters on COVID-19 and Substitution Treatment [GER] [Update Daily]

Drug Reporter | How Harm Reducers Cope with the COVID-19 Pandemic in Europe? [Last update: March, 20th]

MAINline | 8 Corona-Tips voor Mensen die Drugs Gebruiken [NL] [March, 20th]

AFEW International | Mental Health & Psychological Considerations during COVID-19 Outbreak [March, 20th]

Scottish Drug Forum | Guidance on Contingency Planning for People who Use Drugs and COVID-19 (v1.0) [March, 19th]

Echele Cabeza | Consumo de Sustancias Psycoactivas en Cuarentena [SP] [March, 19th]

Zurich Drug Consumption Rooms | COVID-19 Protocols [March, 19th]

Metzineres | COVID-19 Harm Reaction Poster | Flyer (front) | Flyer (back) [March, 19th]

Energy Control | Party & Drugs in the Time of Coronavirus [March, 19th]

YALE | COVID-19 Guidance: Clinicians & Opioid Treatment Programs [March, 18th]

YALE | COVID-19 Guidance: Patients Engaged in Substance Use Treatment [March, 18th]

YALE | Guidance for People Who Use Substances on COVID-19 [March, 18th]

Arild Knutsen | An Open Letter on COVID-19 and PWUD [March, 17th]

DPNSEE | Instructions on Coronavirus for PWUD [Serb] [March, 16th]

Quality Assurance Commission for Substitution Treatment in Germany | Information on Opioid Substitution and COVID-19 – Advice for Physicians [March, 16th]

LANPUD | Drogas y COVID-19 [SP] [March, 14th]

INPUD | Harm Reduction for People Who Use Drugs [March, 13th]

Drug Policy Network SEE | Basic Protective Measures Against the New Coronavirus [March, 11th]

HRC | Safer Drug Use During the COVID-19 Outbreak [March, 11th]

HRC | Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak [March, 11th]

CREW | Coronavirus – General Hygiene Harm Reduction Tips [March, 4th]

 

SEX WORK

ICRSE | Sex Workers Response to COVID-19 in Europe and Central Asia [continuosly updated]
NYC Health | Information on Safer Sex during COVID-19 [March, 21st]
Butterfly Asian and Migrant Sex Workers Support Network & Maggie’s Toronto Sex Workers Action Project |Sex work COVID-19: Guidelines for Sex Workers, Clients, Third Parties, and Allies [March, 19th]

 

GENDER & SEXUAL ORIENTATION

Metzineres | Woman & Gender Non-Conforming People Who Use Drugs Surviving Violence During Quarantine [April, 8th]
NYC Health | Information on Safer Sex during COVID-19 [March, 21st]
GMSH | COVID-19: 2GBTQ MEN [March, 20th]
David Stuart | What does coronavirus (COVID-19) mean in regard to Chemsex? [March, 19th]
Energy Control | Party & Drugs in the Time of Coronavirus [March, 19th]

 

CAPACITY BUILDING

STUDIES | REPORTS | ARTICLES

WEBINARS

FEANTSA | COVID19 & Rough Sleepers [June, 10th]

ISAM | 3rd Webinar on COVID19 and Substance Use [May, 7th]

Alliance for Public Health | COVID-19 Lessons: What can make HIV programs in EECA countries more sustainable? [May, 5th]

ISAM | 2nd Webinar on COVID19 and Substance Use [April, 15th]

INPUD, Medicines du Mond, HRI, UNDOC, WHO | COVID-19 Harm Reduction Programme Implementation [April, 6th]

International AIDS Society | COVID-19 & HIV: What you Need to Know [April, 3rd]

EU Health Policy Platform | COVID-19 European Coordinated Response to the Pandemic [April, 3rd]

CATIE |  Coping with COVID-19: Insight from the Front Lines of HIV, Hepatitis C & Harm Reduction [March, 26th]

Institute for Interdisciplinary Innovation in Healthcare | COVID-19: a Systemic Crisis [March, 25th]

ICPA | Response to COVID-19 in Prisons | Slides | [March, 19th]

ISAM | COVID-19 and Substance Dependence [March, 19th]

Foundation for Opioid Response Efforts | Medications for Opioid Use Disorder and the COVID-19 [March, 19th]

HRC | Harm Reduction, COVID-19, and People Who Use Drugs [March, 18th]

 

PODCASTS

Crack Down |Emergency Measures [March, 20th]

Ten Percent Happier with Dan Harris |How to Handle Coronavirus Anxiety | Special Edition [March, 14th]

Healing Justice | Coronavirus: Wisdom from a Social Justice Lens [March, 13th]

Statement: Harm Reduction Must Go On!

Correlation – European Harm Reduction Network and the Eurasian Harm Reduction Association, together with the Rights Reporter Foundation, published a joint position on the continuity of harm reduction services during the COVID-19 crisis.

Download the English, Russian, German, Portuguese, Spanish, Polish, Hungarian, Czech, Montenegrin PDF version here!

People Who Use Drugs (PWUDs) can be considered as a risk group in the COVID-19 epidemic. They often live at the margins of society with low or no access to housing, employment, financial resources, social and health care, and face systematic discrimination and criminalisation in the majority of countries. Many of them have multiple health problems, which can increase the risk of a (fatal) COVID-19 infection (including long-term diseases such as COPD, HIV, TB, cancer, and other conditions which reduce the immune system). Harm reduction services are often the one and only contact point for PWUDs to access the health service. They provide health and social services as well as other basic support, and function as an essential link to other life-saving services. We call on local and national governments and international organisations introducing safety measures and to:

1. Ensure the continuity and sustainability of harm reduction and other low-threshold services for PWUDs during the COVID-19 epidemic. This includes, in particular, Opiate Substitution Treatment (OST), Heroin Assisted Treatment (HAT), Needle and Syringe Programs (NSP), naloxone provision, and continued access to Drug Consumption Rooms (DCRs). In addition, essential basic services need to be provided, including day and night shelter, showers, clothing, food, and other services. This is of particular importance to those who experience homelessness and/or live on the streets.

2. Provide adequate funding for harm reduction and other low-threshold service providers, and supply them with adequate equipment to protect staff and clients from infections (soap, hand sanitiser, disposable face-masks, tissues etc.).

3. Acknowledge the important and critical role of harm reduction and other low-threshold services in the COVID-19 pandemic and address the specific vulnerable situation of PWUDs and other related groups.

4. Develop specific guidelines and regulations for harm reduction services, with respect to the vulnerable situation of PWUDs and related target groups. These guidelines should be developed in close cooperation with involved staff and the affected communities, and build on international WHO guidelines, recommendations, and evidence and/or national COVID-19 regulations.

More specifically we call for the following:

5. OST and HAT should be maintained and take-home regulations should be established or extended for patients to have the opportunity to come for treatment rarely then ones a week. Access through pharmacies should be ensured.

6. NSP should provide PWUDs with larger amounts of needles, syringes, and other paraphernalia to minimise the number of contacts. Special bins for needles and syringes should be provided to collect used material at home.

7. Harm reduction services should provide COVID-19 prevention material and information for staff, volunteers, and service users, including soap, alcohol-based hand sanitisers that contain at least 60% alcohol, tissues, trash baskets, and disposable face-masks (if this is requested by national regulations), for people who show symptoms like fever, coughing, and sneezing.

8. Drop-in services, day shelters, and DCRs should advise and support PWUDs in preventing COVID-19 infections. Visitors should be made to sanitise their hands when entering and should stay no longer than is absolutely necessary. Kitchens can prepare take-away food to be eaten outdoors. All necessary measures should be made to increase social distancing among visitors/staff with all possible means, and rooms should be ventilated. Overcrowding in harm reductions services, shelters, and DCRs should be avoided, by establishing safety measures, e.g. minimising the duration of stay, maximum number of visitors, entering only once per day. People with permanent housing should be encouraged to stay at home and come only to pick up needles and other harm reduction paraphernalia and tools.

9. The health situation of PWUDs should be monitored closely. If someone shows symptoms, such as fever and coughing, face-masks should be provided and a medical check-up should be ensured. Cooperation agreements with public health services, related health units, and hospitals need to be established to ensure direct medical support, follow up care, and treatment.

10. Night shelters need to be made available for people experiencing homelessness, with a separation in place between those who are not infected and those who are infected and need to be quarantined but do not need specific medical care and treatment in hospitals. Night shelters have to comply with the overall safety regulations for COVID-19, and people should not be exposed to additional risks for infection through overcrowding and insufficient health care.

11. Group-related services, such as meetings and consultations, should be cancelled and postponed until further notice or organised as online services. New treatment admissions should be temporarily suspended. Coercive measures (e.g treatment referrals made by court/prosecutor/police, probation officer visits etc.) should be suspended. Mandatory urine sampling should be abolished.

12. Harm reduction services should establish a safe working environment and make sure that staff are well informed and protected against infection. Service providers should identify critical job functions and positions, and plan for alternative coverage by involving other staff members in service delivery.